Irinotel (Irinotecan)


The agent Irinotecan is a cytostatic and belongs to the therapeutic class of Topoisomerase I inhibitors.


Strength is denoted by disposable cap color.

  • Irinotecan Kabi 40 mg/2 ml
  • Irinotecan Kabi 100 mg/5 ml


Irinotel (Irinotecan) is indicated for the treatment of patients with advanced colorectal cancer:

  • In combination with 5-fluorouracil and folinic acid in patients without prior chemotherapy for advanced disease
  • As a single agent in patients who have failed an established 5-fluorouracil containing treatment regimen

Product Information

If you require any information, please contact Egypt office.

Please refer to the registered and approved SmPC. ​